Milestone Pharmaceuticals Announces Submission of New Drug Application to the U.S. FDA for Etripamil
Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA)…